There is a rationale to consider p53 as a putative prognostic factor of lung cancer: From a theoretical point of view, the p53 mutation resulting in an inactive protein leads to lack of control of cell proliferation by inhibiting the cell cycle arrest in the Gap 1 phase. This evidence concerns the gene TP53 and lung carcinoma.